Infant formula suppliers The A2 Milk Company and Wattle Health Australia have strengthened their regulatory position in the lucrative Chinese market.
A2 Milk announced yesterday its application to continue selling infant formula products in China had been approved by health regulator the China Food and Drug Administration.
Formula manufacturer Synlait Milk, in partnership with A2 Milk since 2010, submitted the mandatory application in May.
Meanwhile, Wattle Health has completed its previously announced $5 million purchase of a 5 per cent stake in Australian infant formula maker Blend & Pack, which is licensed to produce infant formula for China’s market.
As seen in Herald Sun, September 29th 2017.